home / stock / pcvx / pcvx short
Short Information | Vaxcyte Inc. (NASDAQ:PCVX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,844,927 |
Total Actual Volume | 13,445,905 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 92,246 |
Average Short Percentage | 14.50% |
Is there a PCVX Short Squeeze or Breakout about to happen?
See the PCVX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-15-2024 | $68.88 | $71.63 | $71.71 | $68.61 | 689,074 | 182,883 | 26.54% |
05-14-2024 | $66.15 | $67.33 | $67.5 | $65.87 | 321,300 | 49,657 | 15.46% |
05-13-2024 | $65.1 | $65.7 | $65.77 | $64.76 | 491,979 | 100,539 | 20.44% |
05-10-2024 | $65.2 | $65.19 | $66.71 | $64.76 | 533,487 | 128,624 | 24.11% |
05-09-2024 | $65 | $65.57 | $66.48 | $63.63 | 919,834 | 89,917 | 9.78% |
05-08-2024 | $66.45 | $66.79 | $68.22 | $65.81 | 467,620 | 79,854 | 17.08% |
05-07-2024 | $66.4 | $67.52 | $67.755 | $65.86 | 556,995 | 94,470 | 16.96% |
05-06-2024 | $65.41 | $66.4 | $66.85 | $65.315 | 505,234 | 54,453 | 10.78% |
05-03-2024 | $66.48 | $65.96 | $67.08 | $65.46 | 620,649 | 99,745 | 16.07% |
05-02-2024 | $63.83 | $64.55 | $64.9983 | $63.11 | 503,114 | 55,845 | 11.1% |
05-01-2024 | $60.76 | $63.71 | $64.24 | $60.21 | 765,829 | 100,239 | 13.09% |
04-30-2024 | $60.61 | $60.55 | $61.195 | $58.84 | 445,654 | 77,275 | 17.34% |
04-29-2024 | $61.07 | $61.03 | $62.285 | $60.72 | 500,655 | 48,648 | 9.72% |
04-26-2024 | $60.32 | $60.72 | $60.945 | $59.41 | 594,302 | 57,987 | 9.76% |
04-25-2024 | $59.59 | $60.06 | $60.09 | $58.1 | 1,566,189 | 135,724 | 8.67% |
04-24-2024 | $61.05 | $60.3 | $61.98 | $59.97 | 667,923 | 67,479 | 10.1% |
04-23-2024 | $61.79 | $60.88 | $62.56 | $60.83 | 663,706 | 74,494 | 11.22% |
04-22-2024 | $61.47 | $61.6 | $63.22 | $60.91 | 627,167 | 82,974 | 13.23% |
04-19-2024 | $60.46 | $60.83 | $61.92 | $59.39 | 1,344,223 | 149,622 | 11.13% |
04-18-2024 | $62.15 | $60.62 | $62.21 | $60.58 | 660,971 | 114,498 | 17.32% |
News, Short Squeeze, Breakout and More Instantly...
Vaxcyte Inc. Company Name:
PCVX Stock Symbol:
NASDAQ Market:
-- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 Program -- -- VAX-24 In...
2024-04-23 18:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
The global market study pneumococcal conjugate (PCV) market is ~$8 billion per year, and Vaxcyte Inc (NASDAQ:PCVX) estimates it will grow...